Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Shares Stats
Shares Outstanding | 39,610,000 |
Shares Float | 33,690,000 |
Shares Short | 460,000 |
Insider Holdings | 1325% |
Institution Holdings | 67.21% |
About Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
General
Name | Viemed Healthcare Inc |
Ticker | VMD |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Currency | USD |
Country | USA |
Fiscal Year End | December |
Full Time Employees | 1,258 |
Highlights
Analyst Target | 13.00 |
Market Cap | 266,100,000 |
PE Ratio | 20.24 |
EBITDA | 42,878,000 |
Financials
Curr Year EPS Estimate | 0.43 |
Profit Margin | 5.80% |
Operating Margin | 6.89 |
Return on Assets | 0.06 |
Return on Equity | 0.11 |
Revenue | 240.9M |
Earnings Per Share | 0.34 |
Revenue Per Share | 6.14 |
Gross Profit | 140,519,008 |
Quarterly Revenue Growth | 0.15 |
Valuation
Trailing PE | 20.38 |
Forward PE | 16.89 |
Price/Sales (Trailing 12 Mt.) | 1.12 |
Price/Book (Most Recent Quarter) | 1.88 |
Earnings
Trump administration cuts nearly $8B in clean energy projects in blue states
WASHINGTON (AP) — The Trump administration is cancelling $7.6 billion in grants that supported hundreds of clean energy projects in 16 states, all of which voted for Democrat Kamala Harris in last year's presidential election.
Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales
Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
When Bill Gates Questioned Lyft CEO Risher's Move To Jeff Bezos' 'Tiny, Little Internet Bookstore'—'Stupidest Decision' Ever
David Risher, current CEO of Lyft Inc recently shared a bold career move he made in 1996 that earned him a scathing rebuke from Bill Gates.
Two Delta jets damaged in 'low-speed collision' on LaGuardia taxiway, injuring 1
Two Delta Air Lines regional jets collided on the taxiway at LaGuardia Airport in New York, injuring a flight attendant, damaging a cockpit and tearing off part of a wing in what the airline described as a “low-speed collision.”
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Consumer Tech News (Sep. 15 – Sep. 19): Fed Rate Cut Lifts Wall Street To Records As Meta Unveils Smart Glasses, Nvidia-Intel Forge Chip Pact
Wall Street rallied to record highs after the Fed's rate cut, while Meta launched new smart glasses, Nvidia teamed with Intel on chips, and big names like General Mills, FedEx, and Darden reported earnings.
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
3 Gold Mining Stocks Shine As Prices Hit Records
Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.
Jensen Huang Is A 'Good Friend,' Says Intel CEO Lip-Bu Tan Amid News Of Partnership With Nvidia: Next Era Of Computing Coming?
Intel shares surged more than 20% after CEO Lip-Bu Tan announced a landmark partnership with Nvidia's Jensen Huang to co-develop AI chips, a deal that includes a $5 billion Nvidia investment and positions both companies at the center of the next era of computing.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),
Nvidia, Alphabet, Oklo, Webtoon Entertainment And Coreweave: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices ended in the green with the Dow Jones Industrial Average rising 0.1% to 45,883.45.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Steve Jobs Once Paused For 18 Seconds To Answer A Student's Simple Question: Here Is What The Apple Co-Founder Said
Steve Jobs took an 18-second pause before answering a question, showing his habit of thinking first. He values long-term talent development.
Ethereum Co-Founder Vitalik Buterin Responds to Security Concerns Over OpenAI's ChatGPT
Ethereum co-founder Vitalik Buterin has voiced his concerns over potential security risks associated with OpenAI's ChatGPT, which could lead to the leakage of personal user data.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Elon Musk Back Atop Billionaires List, Tesla CEO Almost Recovers Lost Wealth Since Joining Hands With Trump
Elon Musk almost recovers wealth lost since aligning with Trump for 2024 election; now richest person thanks to surging Tesla stocks.
Bitcoin, Ethereum, Dogecoin Consolidate As XRP Tries To Push Higher
Cryptocurrency markets are trading sideways on Tuesday as investors position ahead of the Federal Reserve's interest rate decision.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Democrats embrace a shutdown fight in a rare moment of unity against Trump
NEW YORK (AP) — On this, at least, the Democrats agree: It's time to fight.
Australia warns social media platforms against age verification for all ahead of a ban on children
MELBOURNE, Australia (AP) — Australian authorities said Tuesday that should not demand age verification for all account holders starting from December, when a having accounts goes into effect in the country.
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $3,600, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
Anthony Scaramucci Says A Tesla–xAI Merger 'Feels Inevitable' As Shareholders Push For Investment In Grok Parent
Anthony Scaramucci said a Tesla–xAI merger "feels inevitable," amplifying shareholder pressure and investor debate as Musk backs closer ties between the EV maker and his $100 billion AI startup.
Trump Administration Withdraws Brian Quintenz's Nomination For CFTC Chair, Says President Prioritizes Making America 'Crypto Capital' Of The World
The Trump administration has pulled back the nomination of Brian Quintenz for the chair of the Commodity Futures Trading Commission, a White House official told Benzinga late Tuesday.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet
Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.
In battles over free speech, comedians are often center stage
NEW YORK (AP) — Bassem Youssef, the Egyptian satirist whose after the military seized the once pro-democracy government, watched the suspension of Jimmy Kimmel with an immediate sense of familiarity.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Elon Musk's $1 Trillion Pay Package Is 'A Little Bit Weird' To Compare Monetarily, Says Tesla Board Chair: It's About 'Voting Influence'
Tesla's board chair, Robyn Denholm, defended Elon Musk's $1 trillion compensation package, emphasizing its potential to drive unique performance despite recent sales struggles.
Opendoor Stock Rallies On Expansion And Short Squeeze Hopes
Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust
WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.
Cracker Barrel, D-Wave Quantum, IonQ, Krispy Kreme And Broadcom: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, U.S. stocks closed mixed as the Dow Jones Industrial Average advanced 0.6% to 46,018.32.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected
NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.
Trump Warns Of Massive Debt, Peter Grandich Warns Of 'Most Dangerous Time in 40 Years,' Fed Trapped In Inflation And More: This Week In Economy
Peter Grandich warns that we're in the "most dangerous time in 40 years," as gold surges and the Fed faces challenges with inflation and unemployment.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Nvidia's Market Capitalization Surpasses Canada's GDP, As McKinsey Projects $1.7 Trillion AI Data Center Spend By 2030
Nvidia has become the world's most valuable company with a $4.32 trillion market cap — surpassing Canada's GDP.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.